Annovis Bio, Inc.
NYSE:ANVSBiotechnology
Healthcare
$1.21 +0.00%
+$0.00 today
- Market cap
- $51.64M
- Beta
- 1.24
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$1.47
52W Low $1.54High $5.50
Volume 1.35M
Average 1.08M
Private 5-step workspace
Build a ANVS investment thesis
Turn Annovis Bio, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.